New Applications of Heparin and Other Glycosaminoglycans
Open accessThe DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Abstract
Heparin, the widely used pharmaceutical anticoagulant, has been in clinical use for well over half a century. Its introduction reduced clotting risks substantially and subsequent developments, including the introduction of low-molecular-weight heparin, made possible many major surgical interventions that today make heparin an indispensable drug. There has been a recent burgeoning of interest in heparin and related glycosaminoglycan (GAG) polysaccharides, such as chondroitin sulfates, heparan sulfate, and hyaluronate, as potential agents in various applications. This ability arises mainly from the ability of GAGs to interact with, and alter the activity of, a wide range of proteins. Here, we review new developments (since 2010) in the application of heparin and related GAGs across diverse fields ranging from thrombosis and neurodegenerative disorders to microbiology and biotechnology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intravenous Fluids and Acute Kidney Injury
Ding, X., Cheng, Z., & Qian, Q. (2017) · Blood Purification · doi:10.1159/000452702 · Cited by 6,827
Sapsford, K. E., Algar, W. R., Berti, L., Gemmill, K. B., Casey, B. J., Oh, E., Stewart, M. H., & Medintz, I. L. (2013) · Chemical Reviews · doi:10.1021/cr300143v · Cited by 1,423
Borsig, L., Wong, R., Feramisco, J., Nadeau, D. R., Varki, N. M., & Varki, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061615598 · Cited by 714
Glycosaminoglycans: key players in cancer cell biology and treatment
Afratis, N., Gialeli, C., Nikitovic, D., Tsegenidis, T., Karousou, E., Theocharis, A. D., Pavão, M. S., Tzanakakis, G. N., & Karamanos, N. K. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08529.x · Cited by 554
Schulze, A., Gripon, P., & Urban, S. (2007) · Hepatology · doi:10.1002/hep.21896 · Cited by 445
Molecular Basis for the Relationship Between Thrombosis and Cancer
Rickles, F. R., & Falanga, A. (2001) · Thrombosis Research · doi:10.1016/s0049-3848(01)00285-7 · Cited by 329
Domain Structure of Heparan Sulfates from Bovine Organs
Maccarana, M., Sakura, Y., Tawada, A., Yoshida, K., & Lindahl, U. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.17804 · Cited by 284
Nelson, A., Berkestedt, I., Schmidtchen, A., Ljunggren, L., & Bodelsson, M. (2008) · Shock · doi:10.1097/shk.0b013e3181777da3 · Cited by 271
Broad-spectrum antivirals against viral fusion
Vigant, F., Santos, N. C., & Lee, B. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3475 · Cited by 266
Wang, D., Ichiyama, R. M., Zhao, R., Andrews, M. R., & Fawcett, J. W. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0983-11.2011 · Cited by 205
Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer
Karousou, E., Misra, S., Ghatak, S., Dobra, K., Götte, M., Vigetti, D., Passi, A., Karamanos, N. K., & Skandalis, S. S. (2017) · Matrix Biology · doi:10.1016/j.matbio.2016.10.001 · Cited by 203
Chemoenzymatic synthesis of heparan sulfate and heparin
Liu, J., & Linhardt, R. J. (2014) · Nat. Prod. Rep. · doi:10.1039/c4np00076e · Cited by 200
Holothurian Fucosylated Chondroitin Sulfate
Pomin, V. (2014) · Marine Drugs · doi:10.3390/md12010232 · Cited by 193
Heparan sulfate regulates amyloid precursor protein processing by BACE1, the Alzheimer's β-secretase
Scholefield, Z., Yates, E. A., Wayne, G., Amour, A., McDowell, W., & Turnbull, J. E. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200303059 · Cited by 182
Self-citationCS-4,6 is differentially upregulated in glial scar and is a potent inhibitor of neurite extension
Gilbert, R. J., McKeon, R. J., Darr, A., Calabro, A., Hascall, V. C., & Bellamkonda, R. V. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.04.006 · Cited by 168
Semaphorin 3A Binds to the Perineuronal Nets via Chondroitin Sulfate Type E Motifs in Rodent Brains
Dick, G., Tan, C. L., Alves, J. N., Ehlert, E. M. E., Miller, G. M., Hsieh-Wilson, L. C., Sugahara, K., Oosterhof, A., van Kuppevelt, T. H., Verhaagen, J., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.310029 · Cited by 160
Bacterial biofilm formation on urologic devices and heparin coating as preventive strategy
Tenke, P., Riedl, C. R., Jones, G. L., Williams, G. J., Stickler, D., & Nagy, E. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2003.12.007 · Cited by 159
Läubli, H., Stevenson, J. L., Varki, A., Varki, N. M., & Borsig, L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3121 · Cited by 158
Chondroitin Sulfate Proteoglycans in the Nervous System: Inhibitors to Repair
Siebert, J. R., Conta Steencken, A., & Osterhout, D. J. (2014) · BioMed Research International · doi:10.1155/2014/845323 · Cited by 153
Orlando, C., Ster, J., Gerber, U., Fawcett, J. W., & Raineteau, O. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2406-12.2012 · Cited by 153
Turnbull, J. E., & Gallagher, J. T. (1991) · Biochemical Journal · doi:10.1042/bj2730553 · Cited by 152
Interaction of Zika Virus Envelope Protein with Glycosaminoglycans
Kim, S. Y., Zhao, J., Liu, X., Fraser, K., Lin, L., Zhang, X., Zhang, F., Dordick, J. S., & Linhardt, R. J. (2017) · Biochemistry · doi:10.1021/acs.biochem.6b01056 · Cited by 150
Four Heparin Preparations: Anti-Xa Potentiating Effect of Heparin after Subcutaneous Injection
Johnson, E. A., Kirkwood, T. B. L., Stirling, Y., et al. (1976) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1648001 · Cited by 137
Perlin, A. S., Mackie, D. M., & Dietrich, C. P. (1971) · Carbohydrate Research · doi:10.1016/s0008-6215(00)80341-9 · Cited by 133
Heparin inhibits dengue-2 virus infection of five human liver cell lines
Lin, Y.-L., Lei, H., Lin, Y., et al. (2002) · Antiviral Research · doi:10.1016/s0166-3542(02)00095-5 · Cited by 131
Highly Sensitive Sequencing of the Sulfated Domains of Heparan Sulfate
Merry, C. L. R., Lyon, M., Deakin, J. A., Hopwood, J. J., & Gallagher, J. T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18455 · Cited by 131
Heparin prevents programmed cell death in human trophoblast
Hills, F. A., Abrahams, V. M., Gonzalez-Timon, B., Francis, J., Cloke, B., Hinkson, L., Rai, R., Mor, G., Regan, L., Sullivan, M., et al. (2006) · Molecular Human Reproduction · doi:10.1093/molehr/gal026 · Cited by 124
Antiviral activity of chondroitin sulphate E targeting dengue virus envelope protein
Kato, D., Era, S., Watanabe, I., Arihara, M., Sugiura, N., Kimata, K., Suzuki, Y., Morita, K., Hidari, K. I. P. J., & Suzuki, T. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2010.09.002 · Cited by 119
Fucosylated Chondroitin Sulfates from the Body Wall of the Sea Cucumber Holothuria forskali
Panagos, C. G., Thomson, D., Moss, C., Hughes, A. D., Kelly, M. S., Liu, Y., Chai, W., Venkatasamy, R., Spina, D., Page, C. P., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.572297 · Cited by 113
Larsson, S., Lohmander, S. L., & Struglics, A. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2735 · Cited by 107
Highly Sulfated Forms of Heparin Sulfate Are Involved in Japanese Encephalitis Virus Infection
Su, C.-M., Liao, C., Lee, Y.-L., & Lin, Y. (2001) · Virology · doi:10.1006/viro.2001.0986 · Cited by 97
Reversing anticoagulants both old and new.
Warkentin, T. E., & Crowther, M. A. (2002) · PubMed · Cited by 96
Heparin prevents Zika virus induced-cytopathic effects in human neural progenitor cells
Ghezzi, S., Cooper, L. C., Rubio, A., Pagani, I., Capobianchi, M. R., Ippolito, G., Pelletier, J., Meneghetti, M. C. Z., de Lima, M. A., Skidmore, M. A., et al. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2016.12.023 · Cited by 94
Self-citationDiversification of the Structural Determinants of Fibroblast Growth Factor-Heparin Interactions
Xu, R., Ori, A., Rudd, T. R., Uniewicz, K. A., Ahmed, Y., Guimond, S. E., Skidmore, M. A., Siligardi, G., Yates, E. A., & Fernig, D. G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.398826 · Cited by 90
Self-citationHeparin and Related Drugs: Beyond Anticoagulant Activity
Page, C. P. (2013) · ISRN Pharmacology · doi:10.1155/2013/910743 · Cited by 87
Barrowcliffe, T. W. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-23056-1_1 · Cited by 85
Heparin fractionation by electrofocusing: Presence of 21 components of different molecular weights
Nader, H. B., McDuffie, N. M., & Dietrich, C. P. (1974) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(74)90958-9 · Cited by 82
Structural features of low-molecular-weight heparins affecting their affinity to antithrombin
Bisio, A., Vecchietti, D., Citterio, L., Guerrini, M., Raman, R., Bertini, S., Eisele, G., Naggi, A., Sasisekharan, R., & Torri, G. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-02-0081 · Cited by 78
Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma
Sato, N., Cheng, X., Kohi, S., Koga, A., & Hirata, K. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.01.002 · Cited by 78
Specific Glycosaminoglycans Modulate Neural Specification of Mouse Embryonic Stem Cells
Pickford, C. E., Holley, R. J., Rushton, G., Stavridis, M. P., Ward, C. M., & Merry, C. L. R. (2011) · Stem Cells · doi:10.1002/stem.610 · Cited by 77
The role of heparin and allied compounds in the treatment of sepsis
Cornet, A. D., Smit, E. G. M., Beishuizen, A., & Groeneveld, A. B. J. (2007) · Thrombosis and Haemostasis · doi:10.1160/th07-01-0006 · Cited by 76
Patey, S. J., Edwards, E. A., Yates, E. A., & Turnbull, J. E. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051221o · Cited by 69
Self-citationFiloviruses Utilize Glycosaminoglycans for Their Attachment to Target Cells
Salvador, B., Sexton, N. R., Carrión, R. E., Nunneley, J. W., Patterson, J. L., Steffen, I., Lü, K., Muench, M. O., Lembo, D., & Simmons, G. (2013) · Journal of Virology · doi:10.1128/jvi.01621-12 · Cited by 68
Li, Y., Sun, C., Yates, E. A., Jiang, C., Wilkinson, M. C., & Fernig, D. G. (2016) · Open Biology · doi:10.1098/rsob.150275 · Cited by 68
Self-citationPavão, M. S. G. (2014) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2014.00123 · Cited by 66
Protective and therapeutic effect of heparin in acute pancreatitis.
Ceranowicz, P., DEMBINSKI, A. B., Warzecha, Z., Dembiński, M., Cieszkowski, J., Rembisz, K., Konturek, S. J., Kusnierz-Cabala, B., Tomaszewska, R., & Pawlik, W. W. (2008) · PubMed · Cited by 66
Berger F, Z., Quera P, R., Poniachik T, J., Oksenberg R, D., & Guerrero P, J. (2001) · Revista médica de Chile · doi:10.4067/s0034-98872001001200002 · Cited by 65
Xu, Y., Pempe, E. H., & Liu, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.358523 · Cited by 64
Li, L., Yan, L., Huang, M., Yin, T., Gou, S., Zhan, N.-Y., Xiong, J., Wu, H., Yang, Z., & Wang, C. (2015) · Cytokine · doi:10.1016/j.cyto.2014.12.010 · Cited by 63
Glycosaminoglycan Binding Facilitates Entry of a Bacterial Pathogen into Central Nervous Systems
Chang, Y.-C., Wang, Z., Flax, L. A., Xu, D., Esko, J. D., Nizet, V., & Baron, M. J. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002082 · Cited by 63
Zhang, Z.-Q., Weïwer, M., Li, B., Kemp, M. M., Daman, T. H., & Linhardt, R. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800785t · Cited by 63
Viskov, C., Just, M., Laux, V., Mourier, P. A. J., & Lorenz, M. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03447.x · Cited by 60
McDuffie, N. M., Dietrich, C. P., & Nader, H. B. (1975) · Biopolymers · doi:10.1002/bip.1975.360140713 · Cited by 59
Atomic Details of the Interactions of Glycosaminoglycans with Amyloid-β Fibrils
Stewart, K. L., Hughes, E., Yates, E. A., Akien, G. R., Huang, T., de Lima, M. A., Rudd, T. R., Guerrini, M., Hung, S., Radford, S. E., et al. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b02816 · Cited by 59
Self-citationMontanuy, I., Alejo, A., & Alcamı́, A. (2011) · The FASEB Journal · doi:10.1096/fj.10-177188 · Cited by 57
Ghadiali, R. S., Guimond, S. E., Turnbull, J. E., & Pisconti, A. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.07.007 · Cited by 56
HB-GAM (pleiotrophin) reverses inhibition of neural regeneration by the CNS extracellular matrix
Paveliev, M., Fenrich, K. K., Kislin, M., Kuja-Panula, J., Kulesskiy, E., Varjosalo, M., Kajander, T., Mugantseva, E., Ahonen-Bishopp, A., Khiroug, L., et al. (2016) · Scientific Reports · doi:10.1038/srep33916 · Cited by 55
Duckworth, C. A., Guimond, S. E., Sindrewicz, P., Hughes, A. J., French, N. S., Lian, L.-Y., Yates, E. A., Pritchard, D. M., Rhodes, J. M., Turnbull, J. E., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4409 · Cited by 53
Self-citationXin-sheng, L., Fu, Q., Jie-Qin, L., Qin-qiao, F., Ri-guang, Z., Ai, Y., Kai-Cheng, Z., & Yi-xiong, L. (2009) · Asian Journal of Surgery · doi:10.1016/s1015-9584(09)60017-8 · Cited by 48
New Roles of Glycosaminoglycans in α-Synuclein Aggregation in a Cellular Model of Parkinson Disease
Lehri-Boufala, S., Ouidja, M.-O., Barbier-Chassefière, V., Hénault, E., Raisman-Vozari, R., Garrigue-Antar, L., Papy-Garcia, D., & Morin, C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116641 · Cited by 47
Inhibition of influenza H5N1 invasion by modified heparin derivatives
Skidmore, M. A., Kajaste‐Rudnitski, A., Wells, N., Guimond, S. E., Rudd, T. R., Yates, E. A., & Vicenzi, E. (2014) · MedChemComm · doi:10.1039/c4md00516c · Cited by 46
Self-citationVlodavsky, I., Elkin, M., & Ilan, N. (2011) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10019 · Cited by 45
Outcomes Following the Use of Nebulized Heparin for Inhalation Injury (HIHI Study)
McIntire, A. M., Harris, S. A., Whitten, J. A., et al. (2016) · Journal of Burn Care & Research · doi:10.1097/bcr.0000000000000439 · Cited by 44
Meade, K. A., White, K. J., Pickford, C. E., Holley, R. J., Marson, A., Tillotson, D., Kuppevelt, T. H. V., Whittle, J. D., Day, A. J., & Merry, C. L. R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.423012 · Cited by 43
Schultz, V., Suflita, M., Liu, X.-Y., Zhang, X., Yu, Y.-L., Li, L.-Y., Green, D. E., Xu, Y.-M., Zhang, F.-M., DeAngelis, P., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.761585 · Cited by 42
Inhaled heparin in cystic fibrosis
Serisier, D. J., Shute, J. K., Hockey, P. M., et al. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00069005 · Cited by 41
Assessment of glycosaminoglycan concentration in equine synovial fluid as a marker of joint disease.
PALMER, J. L., Bertone, A. L., & McClain, H. (1995) · PubMed · Cited by 40
Neural ECM in regeneration and rehabilitation
Yang, S., Kwok, J. C. F., & Fawcett, J. W. (2014) · Progress in brain research · doi:10.1016/b978-0-444-63486-3.00008-6 · Cited by 40
Low molecular weight heparin tinzaparin antagonizes cisplatin resistance of ovarian cancer cells
Pfankuchen, D. B., Stölting, D. P., Schlesinger, M., Royer, H., & Bendas, G. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.07.013 · Cited by 37
Chondroitin sulfate-E mediates estrogen-induced osteoanabolism
Koike, T., Mikami, T., Shida, M., Habuchi, O., & Kitagawa, H. (2015) · Scientific Reports · doi:10.1038/srep08994 · Cited by 36
Heparin-like glycosaminoglycans prevent the infection of measles virus in SLAM-negative cell lines
Terao-Muto, Y., Yoneda, M., Seki, T., et al. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2008.08.006 · Cited by 35
Call, D. R., & Remick, D. G. (1998) · Shock · doi:10.1097/00024382-199809000-00007 · Cited by 35
Enhanced Tumorigenic Potential of Colorectal Cancer Cells by Extracellular Sulfatases
Vicente, C. M., de Lima, M. A., Yates, E. A., et al. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0372 · Cited by 34
Self-citationFucosylated Chondroitin Sulfate Inhibits Plasmodium falciparum Cytoadhesion and Merozoite Invasion
Bastos, M. F., Albrecht, L., Kozlowski, E. O., Lopes, S. C. P., Blanco, Y. C., Carlos, B. C., Castiñeiras, C., Vicente, C. P., WERNECK, C. C., Wunderlich, G., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00686-13 · Cited by 32
Skidmore, M. A., Dumax-Vorzet, A. F., Guimond, S. E., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701337t · Cited by 31
Heparin Oligosaccharides as Potential Therapeutic Agents in Senile Dementia
Ma, Q., Cornelli, U., Hanin, I., Jeske, W. P., Linhardt, R. J., Walenga, J. M., Fareed, J., & Lee, J. M. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207780765918 · Cited by 31
Côrtes, L. M. D. C., Pereira, M. C. D. S., da Silva, F. S., et al. (2012) · Parasites & Vectors · doi:10.1186/1756-3305-5-142 · Cited by 28
Heparin derivatives for the targeting of multiple activities in the inflammatory response
Veraldi, N., Hughes, A. J., Rudd, T. R., Thomas, H. B., Edwards, S. W., Hadfield, L. C., Skidmore, M. A., Siligardi, G., Cosentino, C., Shute, J. K., et al. (2014) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2014.09.079 · Cited by 28
Self-citationde Oliveira, F. O. R., Alves, C. R., Souza‐Silva, F., et al. (2012) · Parasitology · doi:10.1017/s0031182011002344 · Cited by 27
Interaction of factor XIa and antithrombin in the presence and absence of heparin
Beeler, D., Marcum, J., Schiffman, S., et al. (1986) · Blood · doi:10.1182/blood.v67.5.1488.1488 · Cited by 27
Nishioka, J., & Goodin, S. (2007) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155207079169 · Cited by 26
Glycans in Diseases and Therapeutics
Pavão, M. S. G. (2011) · Springer eBooks · doi:10.1007/978-3-642-16833-8 · Cited by 24
Xu, Y., Wang, Z., Liu, R., et al. (2011) · Glycobiology · doi:10.1093/glycob/cwr109 · Cited by 24
Theodoraki, A., Hu, Y., Poopalasundaram, S., Oosterhof, A., Guimond, S. E., Disterer, P., Khoo, B. C. E., Hauge-Evans, A. C., Jones, P. M., Turnbull, J. E., et al. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.09.011 · Cited by 21
Shastri, M. D., Peterson, G. M., Stewart, N., Sohal, S. S., & Patel, R. P. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.866092 · Cited by 21
Júdice, W. A. D. S., Manfredi, M. A., Profeta, G. S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080153 · Cited by 20
Using embryonic stem cells to understand how glycosaminoglycans regulate differentiation
Holley, R. J., Meade, K. A., & Merry, C. L. R. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140064 · Cited by 19
Wang, Z., Flax, L. A., Kemp, M. M., Linhardt, R. J., & Baron, M. J. (2010) · Infection and Immunity · doi:10.1128/iai.00254-10 · Cited by 18
Nunes, G. L. C., Simões, A., Dyszy, F. H., Shida, C. S., Juliano, M. A., Juliano, L., Gesteira, T. F., Nader, H. B., Murphy, G., Chaffotte, A. F., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021525 · Cited by 17
Low anticoagulant heparin oligosaccharides as inhibitors of BACE-1, the Alzheimer's β-secretase.
Zhang, X., Zhao, X., Lang, Y.-Z., Li, Q.-Y., Liu, X., Cai, C., Hao, J., Li, G.-Y., & Yu, G.-L. (2016) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2016.05.050 · Cited by 17
Qiu, F., Xin-sheng, L., & Huang, Y.-K. (2012) · Inflammation Research · doi:10.1007/s00011-012-0517-8 · Cited by 16
Kozlowski, E. O., Gomes, A. M., Silva, C. S., Pereira, M. S., Silva, A. C. E. S. D. V., & Pavão, M. S. G. (2011) · Springer eBooks · doi:10.1007/978-3-642-16833-8_7 · Cited by 15
Dietrich, C. P., Nader, H. B., & McDuffie, N. M. (1975) · PubMed · Cited by 13
MYCN-Dependent Expression of Sulfatase-2 Regulates Neuroblastoma Cell Survival
Solari, V., Borriello, L., Turcatel, G., Shimada, H., Sposto, R., Fernández, G. E., Asgharzadeh, S., Yates, E. A., Turnbull, J. E., & DeClerck, Y. A. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2513 · Cited by 12
Self-citationStraus, A. H., Sant’Anna, O. A., Nader, H. B., et al. (1984) · Biochemical Journal · doi:10.1042/bj2200625 · Cited by 10
Antimetastatic Properties of Low Molecular Weight Heparin
Laubli, H. P., Varki, A. P., & Borsig, L. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.66.4607 · Cited by 10
Basic and Clinical Differences of Heparin and Low Molecular Weight Heparin Treatment
Hoppensteadt, D., Iqbal, O., & Fareed, J. (2005) · Elsevier eBooks · doi:10.1016/b978-008044859-6/50022-8 · Cited by 9
Holder, G. M., Bowfield, A., Surman, M., Suepfle, M., Moss, D. A., Tucker, C., Rudd, T. R., Fernig, D. G., Yates, E. A., & Weightman, P. (2012) · Soft Matter · doi:10.1039/c2sm25239b · Cited by 8
Self-citationDetermining the anti-coagulant-independent anti-cancer effects of heparin
Solari, V., Jesudason, E. C., Turnbull, J. E., & Yates, E. A. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605808 · Cited by 6
Self-citationThe use of heparin in the treatment of acute pancreatitis
Trzaskoma, A., Kruczek, M., Rawski, B., Poniewierka, E., & Kempiński, R. (2013) · Polish Journal of Surgery · doi:10.2478/pjs-2013-0035 · Cited by 5
Holley, R. J., Smith, R. A. A., van de Westerlo, E. M. A., et al. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1714-3_21 · Cited by 4
György, B., Tóthfalusi, L., Nagy, G., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.129577c · Cited by 1
Research works printed but not linked: 2
- Gibbon, 1939, The maintenance of life during experimental occlusion of the pulmonary artery followed by survival, Surg Gynecol Obs., 69, 602
- Harenberg, J., and Casu, B. (2012). Nonanticoagulant Actions of Glycosaminoglycans, Springer US.
Cited by
De Masi, R., & Orlando, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137373 · Cited by 20
“The anticoagulant activity is mediated by the activating antithrombin III (a serine protease inhibitor), which, in turn, blocks thrombin, thereby inhibiting blood coagulation factors, Xa and IIa [268].”
BackgroundInfluential
Metadata
- Authors
- Lima, M., Rudd, T., & Yates, E.
- Affiliations
- University of Liverpool (GB)
- Corresponding author
- Lima, Marcelo
- Rudd, Timothy
- Yates, Edwin
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2017-05-06
- Volume
- 22
- Issue
- 5
- Pages
- 749
- ISSN
- 1420-3049 (ISSN-L)
- PMC
- PMC6154012
- OpenAlex
- W2610898931
- Cited by
- 89
- References
- 102
- Citations by year
- 2026: 10 · 2025: 8 · 2024: 6 · 2023: 10 · 2022: 8 · 2021: 18 · 2020: 9 · 2019: 8 · 2018: 10 · 2017: 2
- FWCI
- 0.92
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Molecules (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Keele Research Repository (Keele University) (submittedVersion, cc-by)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Life Sciences › Agricultural and Biological Sciences › Food Science › Polysaccharides Composition and Applications
- Physical Sciences › Materials Science › Surfaces, Coatings and Films › Polymer Surface Interaction Studies
- Keywords
- heparin, glycosaminoglycans, low molecular weight heparin, chondroitin sulfate, heparan sulfate, hyaluronic acid, anticoagulants, thrombosis, neurodegenerative diseases, protein binding, biotechnology applications
- MeSH terms
- Anticoagulants, Biotechnology, Glycosaminoglycans, Humans, Neoplasms, Thrombosis, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.